These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 22812444)
1. Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer. Wu X; Burden-Gulley SM; Yu GP; Tan M; Lindner D; Brady-Kalnay SM; Lu ZR Bioconjug Chem; 2012 Aug; 23(8):1548-56. PubMed ID: 22812444 [TBL] [Abstract][Full Text] [Related]
2. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model. Tan M; Burden-Gulley SM; Li W; Wu X; Lindner D; Brady-Kalnay SM; Gulani V; Lu ZR Pharm Res; 2012 Apr; 29(4):953-60. PubMed ID: 22139536 [TBL] [Abstract][Full Text] [Related]
3. MR molecular imaging of prostate cancer with a small molecular CLT1 peptide targeted contrast agent. Wu X; Lindner D; Yu GP; Brady-Kalnay S; Lu ZR J Vis Exp; 2013 Sep; (79):. PubMed ID: 24056726 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of a targeted nanoglobular dual-modal imaging agent for MR imaging and image-guided surgery of prostate cancer. Tan M; Ye Z; Lindner D; Brady-Kalnay SM; Lu ZR Pharm Res; 2014 Jun; 31(6):1469-76. PubMed ID: 23471641 [TBL] [Abstract][Full Text] [Related]
5. Peptide-targeted Nanoglobular Gd-DOTA monoamide conjugates for magnetic resonance cancer molecular imaging. Tan M; Wu X; Jeong EK; Chen Q; Lu ZR Biomacromolecules; 2010 Mar; 11(3):754-61. PubMed ID: 20131758 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of a polydisulfide with Gd-DOTA monoamide side chains as a biodegradable macromolecular contrast agent for MR blood pool imaging. Ye Z; Wu X; Tan M; Jesberger J; Grisworld M; Lu ZR Contrast Media Mol Imaging; 2013; 8(3):220-8. PubMed ID: 23606425 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography. Kaneshiro TL; Jeong EK; Morrell G; Parker DL; Lu ZR Biomacromolecules; 2008 Oct; 9(10):2742-8. PubMed ID: 18771313 [TBL] [Abstract][Full Text] [Related]
8. Peptide targeted high-resolution molecular imaging of prostate cancer with MRI. Wu X; Yu G; Lindner D; Brady-Kalnay SM; Zhang Q; Lu ZR Am J Nucl Med Mol Imaging; 2014; 4(6):525-36. PubMed ID: 25250202 [TBL] [Abstract][Full Text] [Related]
9. An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix. Tan M; Wu X; Jeong EK; Chen Q; Parker DL; Lu ZR Mol Pharm; 2010 Aug; 7(4):936-43. PubMed ID: 20481565 [TBL] [Abstract][Full Text] [Related]
10. A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent. Ye Z; Zhou Z; Ayat N; Wu X; Jin E; Shi X; Lu ZR Contrast Media Mol Imaging; 2016; 11(1):32-40. PubMed ID: 26218648 [TBL] [Abstract][Full Text] [Related]
11. A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI. Ye F; Wu X; Jeong EK; Jia Z; Yang T; Parker D; Lu ZR Bioconjug Chem; 2008 Dec; 19(12):2300-3. PubMed ID: 19053180 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer. Li Y; Han Z; Roelle S; DeSanto A; Sabatelle R; Schur R; Lu ZR Mol Pharm; 2017 Nov; 14(11):3906-3915. PubMed ID: 28976766 [TBL] [Abstract][Full Text] [Related]
13. Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI. Zhou Z; Wu X; Kresak A; Griswold M; Lu ZR Biomaterials; 2013 Oct; 34(31):7683-93. PubMed ID: 23863450 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents. Tan M; Ye Z; Jeong EK; Wu X; Parker DL; Lu ZR Bioconjug Chem; 2011 May; 22(5):931-7. PubMed ID: 21473650 [TBL] [Abstract][Full Text] [Related]
15. Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer. Lu ZR; Laney V; Li Y Acc Chem Res; 2022 Oct; 55(19):2833-2847. PubMed ID: 36121350 [TBL] [Abstract][Full Text] [Related]
16. Integrin α6-Targeted Magnetic Resonance Imaging of Hepatocellular Carcinoma in Mice. Zhang Y; Zhao J; Cai J; Ye JC; Xiao YT; Mei Y; Zeng MS; Xie CM; Jiang Y; Feng GK Mol Imaging Biol; 2020 Aug; 22(4):864-872. PubMed ID: 31792839 [TBL] [Abstract][Full Text] [Related]